Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the needs of the facial aesthetics market. The company was founded in 2012 and is headquartered in Irvine, California. The company trades on NASDAQ exchange. The company headquarter is located in Irvine, CA. The company was established in the 2012.

TickerEOLS
Long NameEvolus, Inc.
Short NameEvolus